Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.650
-0.500 (-12.05%)
Sep 12, 2025, 2:40 PM CET
Arctic Bioscience AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Operating Revenue | 43.97 | 43.48 | 33.75 | 34.27 | 21.52 | 20.5 | Upgrade |
Other Revenue | 1.93 | 0.92 | 0.01 | 0.2 | 0 | 0.1 | Upgrade |
| 45.9 | 44.4 | 33.76 | 34.47 | 21.52 | 20.59 | Upgrade | |
Revenue Growth (YoY) | 43.96% | 31.55% | -2.07% | 60.21% | 4.48% | -31.45% | Upgrade |
Cost of Revenue | 31.46 | 31.6 | 23.98 | 22.63 | 15.72 | 15.18 | Upgrade |
Gross Profit | 14.44 | 12.81 | 9.78 | 11.84 | 5.8 | 5.41 | Upgrade |
Selling, General & Admin | 23.71 | 25.95 | 23.51 | 21.69 | 17.26 | 10.76 | Upgrade |
Other Operating Expenses | 25.36 | 29.5 | 29.47 | 21.15 | 25.96 | 15.13 | Upgrade |
Operating Expenses | 54.22 | 60.6 | 58.37 | 46.57 | 45.74 | 27.09 | Upgrade |
Operating Income | -39.78 | -47.79 | -48.59 | -34.73 | -39.94 | -21.67 | Upgrade |
Interest Expense | -5.8 | -3.15 | -0.99 | -0 | -0.34 | -0.51 | Upgrade |
Interest & Investment Income | 1.27 | 2.05 | 3.74 | 1.89 | 0.12 | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | 0.95 | 0.95 | 0.33 | 1.47 | -1.78 | -0.42 | Upgrade |
EBT Excluding Unusual Items | -43.36 | -47.93 | -45.51 | -31.36 | -41.94 | -22.59 | Upgrade |
Other Unusual Items | - | - | - | -2.66 | -0.64 | - | Upgrade |
Pretax Income | -43.36 | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade |
Net Income | -43.36 | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade |
Net Income to Common | -43.36 | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade |
Shares Outstanding (Basic) | 26 | 25 | 25 | 24 | 24 | 14 | Upgrade |
Shares Outstanding (Diluted) | 26 | 25 | 25 | 24 | 24 | 14 | Upgrade |
Shares Change (YoY) | 2.94% | -0.26% | 3.88% | 0.60% | 75.31% | - | Upgrade |
EPS (Basic) | -1.66 | -1.89 | -1.79 | -1.39 | -1.75 | -1.63 | Upgrade |
EPS (Diluted) | -1.66 | -1.89 | -1.79 | -1.39 | -1.75 | -1.63 | Upgrade |
Free Cash Flow | -58.42 | -96.17 | -65.07 | -83.96 | -76 | -35.32 | Upgrade |
Free Cash Flow Per Share | -2.24 | -3.79 | -2.56 | -3.43 | -3.12 | -2.54 | Upgrade |
Gross Margin | 31.45% | 28.84% | 28.97% | 34.36% | 26.95% | 26.28% | Upgrade |
Operating Margin | -86.68% | -107.63% | -143.93% | -100.75% | -185.63% | -105.25% | Upgrade |
Profit Margin | -94.48% | -107.95% | -134.83% | -98.71% | -197.90% | -109.70% | Upgrade |
Free Cash Flow Margin | -127.29% | -216.58% | -192.78% | -243.58% | -353.22% | -171.52% | Upgrade |
EBITDA | -38.03 | -44.9 | -43.2 | -31 | -37.42 | -20.48 | Upgrade |
EBITDA Margin | -82.87% | -101.12% | -127.99% | -89.92% | -173.92% | -99.46% | Upgrade |
D&A For EBITDA | 1.75 | 2.89 | 5.38 | 3.73 | 2.52 | 1.19 | Upgrade |
EBIT | -39.78 | -47.79 | -48.59 | -34.73 | -39.94 | -21.67 | Upgrade |
EBIT Margin | -86.68% | -107.62% | -143.93% | -100.75% | -185.63% | -105.25% | Upgrade |
Revenue as Reported | 45.9 | 44.4 | 33.76 | 34.47 | 21.52 | 20.59 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.